Your Advocates Ltd’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.62K Hold
41
﹤0.01% 170
2026
Q1
$2.92K Hold
41
﹤0.01% 167
2025
Q4
$3.36K Hold
41
﹤0.01% 165
2025
Q3
$3.08K Hold
41
﹤0.01% 157
2025
Q2
$3.04K Sell
41
-8
-16% -$557 ﹤0.01% 148
2025
Q1
$3.96K Hold
49
﹤0.01% 145
2024
Q4
$3.83K Buy
49
+8
+20% +$680 ﹤0.01% 145
2024
Q3
$3.85K Hold
41
﹤0.01% 158
2024
Q2
$3.19K Hold
41
﹤0.01% 163
2024
Q1
$3.73K Hold
41
﹤0.01% 154
2023
Q4
$3.17K Hold
41
﹤0.01% 157
2023
Q3
$2.79K Sell
41
-34
-45% -$2.47K ﹤0.01% 181
2023
Q2
$6.09K Buy
75
+20
+36% +$1.6K ﹤0.01% 161
2023
Q1
$4.51K Buy
+55
New +$3.93K ﹤0.01% 140

Other funds holding GEHC

Your Advocates Ltd's GEHC Position: Q2 2026 in Review

Your Advocates Ltd held its GE HealthCare (GEHC) position steady in Q2 2026 at 41 shares worth $2.62K. The position accounts for ﹤0.01% of the portfolio, ranked #170.

Your Advocates Ltd first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $6.09K in Q2 2023. 684 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Your Advocates Ltd held 41 shares of GE HealthCare worth $2.62K as of Q2 2026.
  • Your Advocates Ltd left its GE HealthCare share count unchanged in Q2 2026.
  • GE HealthCare made up ﹤0.01% of Your Advocates Ltd's portfolio in Q2 2026, its #170 holding.
  • Your Advocates Ltd first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Your Advocates Ltd's GE HealthCare position peaked at $6.09K in Q2 2023.
  • 684 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Your Advocates Ltd's 13F filing for Q2 2026, filed 5 Aug 2026.